Leslie Beth Gordon, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Progeria | 60 | 2024 | 188 | 13.280 |
Why?
|
| Lamin Type A | 31 | 2024 | 189 | 3.400 |
Why?
|
| Piperidines | 8 | 2023 | 1656 | 1.630 |
Why?
|
| Pyridines | 6 | 2018 | 2875 | 1.180 |
Why?
|
| Pravastatin | 3 | 2023 | 392 | 1.040 |
Why?
|
| Diphosphonates | 2 | 2016 | 635 | 0.700 |
Why?
|
| RNA Polymerase III | 2 | 2021 | 58 | 0.670 |
Why?
|
| Enzyme Inhibitors | 9 | 2023 | 3713 | 0.660 |
Why?
|
| Farnesyltranstransferase | 5 | 2014 | 71 | 0.650 |
Why?
|
| Pyrroline Carboxylate Reductases | 1 | 2018 | 6 | 0.650 |
Why?
|
| Imidazoles | 2 | 2016 | 1180 | 0.650 |
Why?
|
| Protein Prenylation | 3 | 2016 | 70 | 0.610 |
Why?
|
| Phosphotransferases (Phosphate Group Acceptor) | 1 | 2018 | 18 | 0.610 |
Why?
|
| Fibroblasts | 11 | 2023 | 4142 | 0.500 |
Why?
|
| Fetal Growth Retardation | 1 | 2018 | 580 | 0.470 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2015 | 53 | 0.460 |
Why?
|
| Cell Nucleus | 8 | 2018 | 2910 | 0.460 |
Why?
|
| Protein Precursors | 3 | 2014 | 1132 | 0.440 |
Why?
|
| Blood Proteins | 1 | 2018 | 1173 | 0.410 |
Why?
|
| Cell Biology | 1 | 2012 | 90 | 0.390 |
Why?
|
| Eye Diseases | 1 | 2017 | 653 | 0.390 |
Why?
|
| Werner Syndrome | 2 | 2018 | 12 | 0.380 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2011 | 138 | 0.370 |
Why?
|
| Child | 36 | 2024 | 80158 | 0.350 |
Why?
|
| Aging | 10 | 2022 | 8710 | 0.350 |
Why?
|
| Child, Preschool | 24 | 2024 | 42232 | 0.340 |
Why?
|
| Craniofacial Abnormalities | 1 | 2012 | 319 | 0.330 |
Why?
|
| Bone Diseases, Developmental | 2 | 2020 | 131 | 0.310 |
Why?
|
| Atherosclerosis | 4 | 2014 | 3407 | 0.310 |
Why?
|
| Drug Discovery | 1 | 2016 | 1051 | 0.310 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2021 | 461 | 0.300 |
Why?
|
| Adolescent | 28 | 2024 | 88326 | 0.290 |
Why?
|
| Lipodystrophy | 2 | 2023 | 145 | 0.270 |
Why?
|
| Clinical Trials as Topic | 5 | 2020 | 8002 | 0.260 |
Why?
|
| Carotid Artery Diseases | 1 | 2011 | 877 | 0.250 |
Why?
|
| Carotid Arteries | 3 | 2016 | 941 | 0.240 |
Why?
|
| Infant | 15 | 2024 | 36193 | 0.230 |
Why?
|
| Nuclear Proteins | 3 | 2014 | 5799 | 0.210 |
Why?
|
| Cerebrospinal Fluid | 2 | 1998 | 544 | 0.210 |
Why?
|
| Bone and Bones | 4 | 2016 | 2568 | 0.190 |
Why?
|
| Age Determination by Skeleton | 2 | 2020 | 126 | 0.190 |
Why?
|
| Mutation | 11 | 2024 | 30053 | 0.190 |
Why?
|
| Optic Atrophy | 1 | 2021 | 79 | 0.180 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 1998 | 1784 | 0.180 |
Why?
|
| Humans | 61 | 2024 | 761596 | 0.180 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 1055 | 0.180 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2021 | 105 | 0.180 |
Why?
|
| C-Reactive Protein | 2 | 2018 | 3826 | 0.170 |
Why?
|
| Hyaluronic Acid | 1 | 2003 | 483 | 0.170 |
Why?
|
| Disease Progression | 5 | 2021 | 13510 | 0.160 |
Why?
|
| Developmental Disabilities | 1 | 2007 | 1509 | 0.160 |
Why?
|
| Female | 34 | 2024 | 392705 | 0.160 |
Why?
|
| Male | 30 | 2024 | 360846 | 0.150 |
Why?
|
| Phenotype | 8 | 2024 | 16592 | 0.150 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2018 | 21 | 0.150 |
Why?
|
| Cholesterol, HDL | 1 | 2005 | 1814 | 0.150 |
Why?
|
| Education | 1 | 2021 | 537 | 0.150 |
Why?
|
| Mast-Cell Sarcoma | 1 | 1997 | 46 | 0.150 |
Why?
|
| Myoglobin | 1 | 2018 | 159 | 0.150 |
Why?
|
| Interleukin-1alpha | 1 | 2018 | 86 | 0.150 |
Why?
|
| Alkyl and Aryl Transferases | 3 | 2014 | 86 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 1651 | 0.150 |
Why?
|
| Interleukin-7 | 1 | 2018 | 143 | 0.140 |
Why?
|
| Alternative Splicing | 2 | 2021 | 1093 | 0.140 |
Why?
|
| Eyebrows | 1 | 2017 | 37 | 0.140 |
Why?
|
| beta 2-Microglobulin | 1 | 2018 | 329 | 0.140 |
Why?
|
| Skin | 5 | 2014 | 4484 | 0.140 |
Why?
|
| Bone Development | 1 | 2020 | 472 | 0.140 |
Why?
|
| Refraction, Ocular | 1 | 2017 | 184 | 0.130 |
Why?
|
| Eyeglasses | 1 | 2017 | 137 | 0.130 |
Why?
|
| Sexual Maturation | 1 | 2017 | 261 | 0.130 |
Why?
|
| Metalloendopeptidases | 3 | 2024 | 393 | 0.130 |
Why?
|
| Interleukin-13 | 1 | 2018 | 392 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 6484 | 0.130 |
Why?
|
| Cause of Death | 2 | 2018 | 3683 | 0.130 |
Why?
|
| Eyelid Diseases | 1 | 2017 | 157 | 0.120 |
Why?
|
| Gingival Recession | 1 | 2018 | 205 | 0.120 |
Why?
|
| Drug Therapy, Combination | 2 | 2016 | 6312 | 0.120 |
Why?
|
| Adenine | 1 | 2021 | 987 | 0.120 |
Why?
|
| Isothiocyanates | 1 | 2014 | 49 | 0.120 |
Why?
|
| Mummies | 1 | 2014 | 10 | 0.120 |
Why?
|
| Dimethylallyltranstransferase | 1 | 2014 | 8 | 0.120 |
Why?
|
| Puberty | 1 | 2017 | 501 | 0.120 |
Why?
|
| Sirolimus | 2 | 2023 | 1533 | 0.120 |
Why?
|
| Mosaicism | 1 | 2016 | 475 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2018 | 1974 | 0.110 |
Why?
|
| Prospective Studies | 8 | 2023 | 54423 | 0.110 |
Why?
|
| Longitudinal Studies | 4 | 2023 | 14608 | 0.100 |
Why?
|
| Exons | 2 | 2016 | 2391 | 0.100 |
Why?
|
| Membrane Proteins | 3 | 2024 | 7859 | 0.100 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 1997 | 1092 | 0.100 |
Why?
|
| Syndrome | 3 | 2014 | 3267 | 0.090 |
Why?
|
| Corneal Diseases | 1 | 2017 | 542 | 0.090 |
Why?
|
| Genes, Dominant | 1 | 2014 | 852 | 0.090 |
Why?
|
| Acoustic Impedance Tests | 1 | 2011 | 110 | 0.090 |
Why?
|
| Cardiovascular Diseases | 4 | 2022 | 15502 | 0.090 |
Why?
|
| Central Nervous System | 1 | 1998 | 1336 | 0.090 |
Why?
|
| Young Adult | 6 | 2023 | 59260 | 0.090 |
Why?
|
| Ankle Brachial Index | 1 | 2011 | 163 | 0.090 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2011 | 139 | 0.090 |
Why?
|
| Rare Diseases | 1 | 2016 | 622 | 0.090 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 6403 | 0.090 |
Why?
|
| Ovalbumin | 1 | 1992 | 677 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3810 | 0.090 |
Why?
|
| Pulsatile Flow | 1 | 2011 | 321 | 0.090 |
Why?
|
| Hearing Loss, Conductive | 1 | 2011 | 159 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2016 | 18966 | 0.080 |
Why?
|
| Age Determination by Teeth | 1 | 2009 | 10 | 0.080 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2009 | 22 | 0.080 |
Why?
|
| Vomiting | 1 | 2012 | 651 | 0.080 |
Why?
|
| Tooth Abnormalities | 1 | 2009 | 56 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 1702 | 0.080 |
Why?
|
| Anodontia | 1 | 2009 | 50 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 2057 | 0.080 |
Why?
|
| Case-Control Studies | 4 | 2020 | 22176 | 0.080 |
Why?
|
| Radiography | 3 | 2020 | 6965 | 0.080 |
Why?
|
| Germ-Line Mutation | 1 | 2016 | 1858 | 0.080 |
Why?
|
| Contracture | 2 | 2008 | 235 | 0.080 |
Why?
|
| Bone Demineralization, Pathologic | 1 | 2007 | 7 | 0.080 |
Why?
|
| Immunization | 1 | 1992 | 1227 | 0.070 |
Why?
|
| Myocardium | 2 | 2018 | 4725 | 0.070 |
Why?
|
| Tooth Eruption | 1 | 2007 | 29 | 0.070 |
Why?
|
| Blood Flow Velocity | 1 | 2011 | 1371 | 0.070 |
Why?
|
| Heart | 2 | 2018 | 4404 | 0.070 |
Why?
|
| Visual Acuity | 1 | 2017 | 2672 | 0.070 |
Why?
|
| Femoral Artery | 1 | 2011 | 826 | 0.070 |
Why?
|
| Angiography | 1 | 2012 | 1595 | 0.070 |
Why?
|
| Forecasting | 2 | 2014 | 2928 | 0.070 |
Why?
|
| DNA Damage | 3 | 2016 | 2449 | 0.070 |
Why?
|
| Femur Head Necrosis | 1 | 2007 | 132 | 0.070 |
Why?
|
| Laminin | 1 | 2008 | 408 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2011 | 5035 | 0.070 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 2244 | 0.070 |
Why?
|
| Incisor | 1 | 2007 | 174 | 0.070 |
Why?
|
| Animals | 13 | 2023 | 168475 | 0.070 |
Why?
|
| Retinoblastoma Protein | 1 | 2010 | 672 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2023 | 4671 | 0.070 |
Why?
|
| Head | 1 | 2012 | 924 | 0.070 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2006 | 141 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 17904 | 0.060 |
Why?
|
| Infant, Newborn | 5 | 2021 | 26202 | 0.060 |
Why?
|
| Adult | 10 | 2023 | 221210 | 0.060 |
Why?
|
| Cerebrovascular Disorders | 1 | 2012 | 1474 | 0.060 |
Why?
|
| Diarrhea | 1 | 2012 | 1318 | 0.060 |
Why?
|
| Fatigue | 1 | 2012 | 1552 | 0.060 |
Why?
|
| Genotype | 2 | 2024 | 12990 | 0.060 |
Why?
|
| Brain | 3 | 1998 | 27121 | 0.060 |
Why?
|
| Dermatomyositis | 1 | 2008 | 258 | 0.060 |
Why?
|
| Cell Nucleus Structures | 1 | 2004 | 15 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2018 | 41495 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 4853 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3639 | 0.060 |
Why?
|
| Transferases | 1 | 2023 | 72 | 0.060 |
Why?
|
| Disease Management | 1 | 2015 | 2508 | 0.060 |
Why?
|
| Mice | 8 | 2023 | 81539 | 0.060 |
Why?
|
| Bone Resorption | 1 | 2007 | 723 | 0.060 |
Why?
|
| Joint Diseases | 1 | 2007 | 459 | 0.050 |
Why?
|
| Congresses as Topic | 1 | 2008 | 803 | 0.050 |
Why?
|
| Electrophoresis | 1 | 2003 | 227 | 0.050 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2003 | 136 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2006 | 585 | 0.050 |
Why?
|
| Cell Line | 5 | 2018 | 15601 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 2013 | 1667 | 0.050 |
Why?
|
| Blood Pressure | 3 | 2018 | 8481 | 0.050 |
Why?
|
| Weight Gain | 1 | 2012 | 2348 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2006 | 829 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2006 | 699 | 0.050 |
Why?
|
| Stem Cells | 2 | 2008 | 3524 | 0.050 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 18255 | 0.050 |
Why?
|
| Antibodies | 3 | 2006 | 2418 | 0.050 |
Why?
|
| Base Pairing | 1 | 2021 | 140 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 10766 | 0.040 |
Why?
|
| Anthropometry | 2 | 2017 | 1349 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2005 | 881 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 39106 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 1492 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 12463 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2003 | 1541 | 0.040 |
Why?
|
| Sample Size | 1 | 2022 | 841 | 0.040 |
Why?
|
| Ataxia | 1 | 2021 | 306 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3246 | 0.040 |
Why?
|
| Adiponectin | 1 | 2005 | 1113 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 1998 | 6214 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2021 | 491 | 0.040 |
Why?
|
| Absorptiometry, Photon | 2 | 2017 | 1738 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2020 | 80647 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 9542 | 0.040 |
Why?
|
| Ribosomal Protein S6 | 1 | 2018 | 71 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2014 | 64685 | 0.040 |
Why?
|
| Heart Murmurs | 1 | 2018 | 92 | 0.040 |
Why?
|
| Point Mutation | 1 | 2003 | 1595 | 0.040 |
Why?
|
| China | 1 | 2024 | 2374 | 0.040 |
Why?
|
| Creatinine | 1 | 2003 | 1899 | 0.040 |
Why?
|
| Transplantation, Heterotopic | 1 | 1997 | 174 | 0.040 |
Why?
|
| Canada | 1 | 2023 | 2122 | 0.040 |
Why?
|
| Nuclear Lamina | 1 | 2016 | 47 | 0.030 |
Why?
|
| Body Weight | 1 | 2007 | 4618 | 0.030 |
Why?
|
| Facies | 2 | 2009 | 222 | 0.030 |
Why?
|
| Collagen | 1 | 2005 | 2638 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 1997 | 621 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2016 | 163 | 0.030 |
Why?
|
| Histocompatibility | 1 | 1997 | 317 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 1997 | 309 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2021 | 918 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2023 | 1588 | 0.030 |
Why?
|
| Mastocytosis | 1 | 1998 | 150 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 1997 | 9032 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 1997 | 681 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 1997 | 445 | 0.030 |
Why?
|
| Splenectomy | 1 | 1997 | 391 | 0.030 |
Why?
|
| Connexin 43 | 1 | 2016 | 200 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 1998 | 1762 | 0.030 |
Why?
|
| Superoxides | 1 | 2016 | 387 | 0.030 |
Why?
|
| Walking | 1 | 2023 | 1198 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 2382 | 0.030 |
Why?
|
| Sulfoxides | 1 | 2014 | 48 | 0.030 |
Why?
|
| Aged | 4 | 2023 | 169310 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2014 | 283 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1997 | 662 | 0.030 |
Why?
|
| Lipids | 1 | 2005 | 3341 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 1997 | 2016 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2023 | 2421 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 11904 | 0.030 |
Why?
|
| Longevity | 1 | 2021 | 1065 | 0.030 |
Why?
|
| Boston | 2 | 2017 | 9327 | 0.030 |
Why?
|
| Immune System | 1 | 1998 | 796 | 0.030 |
Why?
|
| Aorta | 1 | 2021 | 2041 | 0.030 |
Why?
|
| Middle Aged | 3 | 2023 | 220921 | 0.030 |
Why?
|
| Freund's Adjuvant | 1 | 1992 | 149 | 0.030 |
Why?
|
| Research Design | 1 | 2008 | 6180 | 0.030 |
Why?
|
| Spleen | 1 | 1998 | 2295 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 1998 | 1359 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 2088 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4576 | 0.020 |
Why?
|
| Caudate Nucleus | 1 | 1992 | 390 | 0.020 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2011 | 210 | 0.020 |
Why?
|
| RNA | 1 | 2021 | 2725 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 1992 | 477 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 1998 | 1964 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2014 | 1757 | 0.020 |
Why?
|
| Cell Division | 1 | 2018 | 4465 | 0.020 |
Why?
|
| Stroke | 1 | 2012 | 9758 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1992 | 1379 | 0.020 |
Why?
|
| Cerebral Ventricles | 1 | 1992 | 542 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2024 | 5496 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 26129 | 0.020 |
Why?
|
| Blood | 1 | 1992 | 596 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 6131 | 0.020 |
Why?
|
| Alleles | 1 | 2021 | 6864 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2010 | 427 | 0.020 |
Why?
|
| Leptin | 1 | 2017 | 1597 | 0.020 |
Why?
|
| Growth Plate | 1 | 2011 | 274 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2011 | 363 | 0.020 |
Why?
|
| Rats | 2 | 1998 | 23741 | 0.020 |
Why?
|
| Injections | 1 | 1992 | 831 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 11461 | 0.020 |
Why?
|
| Autophagy | 1 | 2016 | 1327 | 0.020 |
Why?
|
| Foot | 1 | 1992 | 575 | 0.020 |
Why?
|
| Acanthosis Nigricans | 1 | 2008 | 47 | 0.020 |
Why?
|
| Body Composition | 1 | 2017 | 2426 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 1321 | 0.020 |
Why?
|
| Malocclusion | 1 | 2009 | 131 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2011 | 23996 | 0.020 |
Why?
|
| Hirsutism | 1 | 2008 | 68 | 0.020 |
Why?
|
| Panniculitis | 1 | 2008 | 45 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 14665 | 0.020 |
Why?
|
| Alveolar Process | 1 | 2009 | 294 | 0.020 |
Why?
|
| Bone Remodeling | 1 | 2011 | 581 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 2192 | 0.020 |
Why?
|
| Facial Dermatoses | 1 | 2008 | 86 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2005 | 12953 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2010 | 23447 | 0.020 |
Why?
|
| DNA | 1 | 2021 | 7213 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2018 | 8321 | 0.020 |
Why?
|
| Prevalence | 1 | 2024 | 15733 | 0.020 |
Why?
|
| Mouth Diseases | 1 | 2009 | 241 | 0.020 |
Why?
|
| Body Fat Distribution | 1 | 2008 | 245 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2016 | 10451 | 0.020 |
Why?
|
| Aggrecans | 1 | 2006 | 89 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1992 | 2048 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2006 | 123 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2008 | 437 | 0.020 |
Why?
|
| Growth | 1 | 2008 | 365 | 0.020 |
Why?
|
| Aging, Premature | 1 | 2006 | 44 | 0.020 |
Why?
|
| Pyrophosphatases | 1 | 2006 | 142 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2006 | 284 | 0.020 |
Why?
|
| Homeostasis | 1 | 2016 | 3323 | 0.020 |
Why?
|
| Free Radicals | 1 | 2005 | 238 | 0.020 |
Why?
|
| Echocardiography | 1 | 2018 | 4989 | 0.020 |
Why?
|
| Muscular Atrophy | 1 | 2008 | 334 | 0.020 |
Why?
|
| Hypertriglyceridemia | 1 | 2008 | 293 | 0.020 |
Why?
|
| Body Height | 1 | 2011 | 1570 | 0.020 |
Why?
|
| Proteome | 1 | 2014 | 1862 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2018 | 6377 | 0.010 |
Why?
|
| Base Sequence | 2 | 2007 | 12441 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1997 | 4446 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 695 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 1779 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2006 | 618 | 0.010 |
Why?
|
| Mitochondria | 1 | 2016 | 3624 | 0.010 |
Why?
|
| Calcium | 1 | 2016 | 5722 | 0.010 |
Why?
|
| DNA Primers | 1 | 2007 | 2820 | 0.010 |
Why?
|
| Uniparental Disomy | 1 | 2003 | 45 | 0.010 |
Why?
|
| Nuclear Envelope | 1 | 2004 | 163 | 0.010 |
Why?
|
| Exanthema | 1 | 2008 | 503 | 0.010 |
Why?
|
| Chromosomes | 1 | 2005 | 578 | 0.010 |
Why?
|
| Transgenes | 1 | 2006 | 1010 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2003 | 211 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3779 | 0.010 |
Why?
|
| Fatty Liver | 1 | 2008 | 790 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 2009 | 1423 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2016 | 14417 | 0.010 |
Why?
|
| Proteomics | 1 | 2014 | 3848 | 0.010 |
Why?
|
| Geriatrics | 1 | 2005 | 388 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2003 | 638 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2004 | 1494 | 0.010 |
Why?
|
| Algorithms | 1 | 2020 | 14033 | 0.010 |
Why?
|
| Calcinosis | 1 | 2008 | 1469 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2008 | 2118 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2005 | 1768 | 0.010 |
Why?
|
| Mitosis | 1 | 2004 | 1188 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2003 | 2467 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2005 | 1243 | 0.010 |
Why?
|
| Actins | 1 | 2006 | 2050 | 0.010 |
Why?
|
| Homozygote | 1 | 2003 | 1776 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 22174 | 0.010 |
Why?
|
| Bone Density | 1 | 2011 | 3551 | 0.010 |
Why?
|
| Genome | 1 | 2005 | 1740 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 4125 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2003 | 2510 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 4740 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2004 | 2932 | 0.010 |
Why?
|
| Pedigree | 1 | 2003 | 4542 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 4111 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2005 | 3113 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2008 | 3964 | 0.010 |
Why?
|
| Cell Movement | 1 | 2006 | 5205 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 3687 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 21355 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2006 | 3549 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 12794 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 12690 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2007 | 58984 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 9177 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 15843 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 9469 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 18399 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 20568 | 0.000 |
Why?
|
| Time Factors | 1 | 2008 | 39969 | 0.000 |
Why?
|